Page last updated: 2024-08-24

xanomeline and Cognitive Manifestations

xanomeline has been researched along with Cognitive Manifestations in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bodick, NC; Lucas, R; Offen, WW; Paul, SM; Satterwhite, J; Shannon, HE; van Lier, R	1

Trials

1 trial(s) available for xanomeline and Cognitive Manifestations

Article	Year
The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease. Alzheimer disease and associated disorders, 1997, Volume: 11 Suppl 4 Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Behavioral Symptoms; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Agonists; Neurobehavioral Manifestations; Neuropsychological Tests; Psychometrics; Psychotropic Drugs; Pyridines; Thiadiazoles; Treatment Outcome	1997

Article

Year

The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease.

Alzheimer disease and associated disorders, 1997, Volume: 11 Suppl 4

Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Behavioral Symptoms; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Agonists; Neurobehavioral Manifestations; Neuropsychological Tests; Psychometrics; Psychotropic Drugs; Pyridines; Thiadiazoles; Treatment Outcome

1997